What Researchers Did
Doctors in Japan described the case of one 63-year-old man with severe, worsening leg ulcers who was treated with wound care, hyperbaric oxygen and 20 sessions of a blood-purification device called Rheocarna.
What They Found
This single case report describes a 63-year-old man with chronic kidney disease, diabetes and chronic limb-threatening ischemia (CLTI) whose circulation and ulcer healing improved and who avoided amputation after wound care, hyperbaric oxygen and 20 Rheocarna sessions. Angiography showed severe arterial calcification, and no targets for standard revascularization were found. Rheocarna removes low-density lipoprotein cholesterol and fibrinogen from the blood. The authors say Rheocarna may be a promising therapy for CLTI patients who cannot have revascularization.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This is a report on a single patient, treatment was combined, and the authors themselves state that further studies are needed to confirm that Rheocarna works.